United States · FDA National Drug Code directory
CREXONT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64896-967_61f8ee81-fe48-4f07-8c6b-aad4701c7f8b
- Product NDC
- 64896-967
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- carbidopa and levodopa
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240809
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBIDOPA HYDRATE — 35 mg/1
- LEVODOPA — 140 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (64896-967-16) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE · 64896-967-16
- 1 BOTTLE in 1 CARTON (64896-967-23) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE · 64896-967-23
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →